Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health)
Cervical Intraepithelial Neoplasia Clinical Trials
A listing of Cervical Intraepithelial Neoplasia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Chandler : New Horizons Women's Care, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Phoenix :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Phoenix : Precision Trials
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Phoenix : Arizona OB/GYN Affiliates, PC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Tucson :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
View More »
Tucson : Visions Clinical Research - Tucson
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
California
Colton :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
La Mesa :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
La Mesa : Grossmont Center for Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Los Angeles :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Colorado
Lakewood :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Florida
Lake Worth : Altus Research
Vaccine for Patients Who Have an Abnormal PAP Smear (Cervical Intraepithelial Neoplasia Grade 2 or 3)
View More »
Boynton Beach :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Boynton Beach : Visions Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Ft. Lauderdale :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Lake Worth : Altus Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Sarasota :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Illinois
Chicago : Center for Women
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Maryland
Baltimore :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Montana
Missoula :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
New York
Bronx : Biomedical Research Alliance of New York
Cervical Intraepithelial Neoplasia (CIN) - Females
View More »
Bronx :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Bronx : Montefiore Medical Center
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
New York : New York Downtown Hospital
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Port Jefferson :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
North Carolina
Winston-Salem :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Ohio
Columbus :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Oklahoma
Oklahoma city :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Oregon
Eugene :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Pennsylvania
Philadelphia :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
South Carolina
Mrytle Beach :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Texas
San Antonio : InVisions Consultants, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
San Antonio : InVisions Consultants, LLC- c/o Institute for Women's Health
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Utah
Murray :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Pleasant Grove :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Salt Lake City : Wasatch Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Sandy :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Virginia
Richmond :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Washington
Renton :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Spokane :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Australia
Victoria :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Canada
Montreal :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Vancouver B.C. :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
China
Beijing : Cancer Institute ＆ Hospital Chinese Academy of Medical Sciences
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine
Nanjing : Jiangsu Provincial Centre for Disease Control and Prevention
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Georgia
Batumi :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Tbilisi :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
India
Bangalore :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Jaipur :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
New Delhi :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Pune :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Korea, Republic of
Seoul :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Puerto Rico
San Juan :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
South Africa
Bloemfontein :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Cape Town :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
